Albemarle swings to $414 million Q4 loss on 16% sales rise, tax and asset charges
Albemarle reported fourth-quarter 2025 net sales of $1.4 billion, up 16% year over year, but a net loss attributable to the company of $414 million, or $3.87 per diluted share, versus earnings of $0.29 per share a year earlier. The company said the loss reflects tax-related items and a write-down of assets tied to the expected Ketjen transaction value, and it introduced 2026 outlook scenarios based on lithium prices.
Key points
- Q4 2025 net sales of $1.4 billion, up 16%; adjusted diluted loss per share of $0.53 versus $1.09 a year earlier
- Q4 2025 net loss of $414 million, or $3.87 per diluted share, versus earnings of $0.29 per share in Q4 2024
- 2026 outlook at a lithium price of about $20 per kg (January 2026 average): net sales of $5.7 to $6.0 billion and adjusted EBITDA of $2.4 to $2.6 billion
- Sale of a controlling stake in Ketjen is on track to close in Q1 2026
The filing
Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.